Antidiabetic Drugs and Prostate Cancer Prognosis in a Finnish Population-Based Cohort.

Ville J VihervuoriKirsi TalalaKimmo TaariJorma LahtelaTeuvo L J TammelaAnssi AuvinenPaavo RaittinenTeemu J Murtola

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)

Type 2 diabetes should be considered as a risk factor when considering prostate cancer prognosis.

Keyphrases

prostate cancer
type diabetes
radical prostatectomy
risk factors
cardiovascular disease
insulin resistance